Volume | 69,076 |
|
|||||
News | (1) | ||||||
Day High | 21.8697 | Low High |
|||||
Day Low | 19.12 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Pharvaris NV | PHVS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
19.79 | 19.12 | 21.8697 | 20.18 | 19.55 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,403 | 69,076 | $ 20.64 | $ 1,425,618 | - | 8.20 - 33.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:24:48 | 1 | $ 19.91 | USD |
Pharvaris NV Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
837.28M | 40.82M | - | 0 | -100.88M | -2.47 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Pharvaris NV News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHVS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 21.70 | 21.8697 | 19.12 | 20.11 | 103,486 | -1.52 | -7.00% |
1 Month | 22.56 | 25.50 | 19.12 | 21.82 | 65,144 | -2.38 | -10.55% |
3 Months | 23.10 | 27.464 | 17.57 | 22.40 | 73,970 | -2.92 | -12.64% |
6 Months | 16.43 | 33.00 | 16.20 | 25.57 | 120,657 | 3.75 | 22.82% |
1 Year | 8.68 | 33.00 | 8.20 | 22.90 | 86,974 | 11.50 | 132.49% |
3 Years | 20.50 | 33.00 | 1.77 | 12.66 | 192,035 | -0.32 | -1.56% |
5 Years | 25.00 | 42.86 | 1.77 | 13.53 | 183,835 | -4.82 | -19.28% |
Pharvaris NV Description
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. |